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background. Legislative actions and advanced technologies, particularly dissemination of safety-engineered devices, have aided in pro-
tecting healthcare personnel from occupational blood and body fluid exposures (BBFE).
objective. To investigate the trends in BBFE among healthcare personnel over 15 years and the impact of safety-engineered devices on the
incidence of percutaneous injuries as well as features of injuries associated with these devices.
methods. Retrospective cohort study at University of North Carolina Hospitals, a tertiary care academic facility. Data on BBFE in healthcare
personnel were extracted from Occupational Health Service records (2000–2014). Exposures associated with safety-engineered and conven-
tional devices were compared. Generalized linear models were applied to measure the annual incidence rate difference by exposure type
over time.
results. A total of 4,300 BBFE, including 3,318 percutaneous injuries (77%), were reported. The incidence rate for overall BBFE was
significantly reduced during 2000–2014 (incidence rate difference, 1.72; P= .0003). The incidence rate for percutaneous injuries was also
dramatically reduced during 2001–2006 (incidence rate difference, 1.37; P= .0079) but was less changed during 2006–2014. Percutaneous
injuries associated with safety-engineered devices accounted for 27% of all BBFE. BBFE was most commonly due to injecting through skin,
placing intravenous catheters, and blood drawing.
conclusions. Our study revealed significant overall reduction in BBFE and percutaneous injuries likely due in part to the impact of safety-
engineered devices but also identified that a considerable proportion of percutaneous injuries is now associated with these devices. Additional
prevention strategies are needed to further reduce percutaneous injuries and improve design of safety-engineered devices.
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Occupational blood and body fluid exposures (BBFE) to
bloodborne pathogens (BBP) remain a serious public health
concern.1 More than 50 pathogens have been documented to
cause infection following BBFE to healthcare personnel
(HCP).2 However, the most important BBP are hepatitis B
virus (HBV), hepatitis C virus (HCV), and human immuno-
deficiency virus (HIV).2,3 Percutaneous injuries are the most
frequent cause of occupationally acquired HBV, HCV, and
HIV. It has been estimated that approximately 385,000
percutaneous injuries occurred annually among HCP in the
United States in the period of 1997 to 1998.1,4 Direct costs of
follow-up for HCP with percutaneous injuries have ranged
from $500 to $3,000.5,6
The Needlestick Safety and Prevention Act was enacted in
the United States in 2001 and requires employers to provide
HCP with safety-engineered devices and to document
needlestick injuries.7 Legislative actions and advanced tech-
nologies, especially dissemination of safety-engineered devices,
have aided in protecting HCP from occupational exposures
to BBP.8,9 Currently, a variety of safety-engineered devices
are commercially available, including more than 300
safety-engineered devices on the US market and more than
1,700 needlestick prevention devices with US patents.9 During
an 11-year period (1995–2005), percutaneous injuries were
estimated to be reduced by approximately 40% as a result of
implementation in 2001 of the Needlestick Safety and
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Prevention Act.10 However, injuries associated with safety-
engineered devices now account for a substantial proportion of
percutaneous injuries.11,12
Because few data are available on the overall reduction in
BBFE since 2006, we undertook the following study whose
goals were as follows: (1) to examine the trends in BBFE by
nature of injury among HCP at University of North Carolina
(UNC) Hospitals over the past 15 years and the relationship
between exposures, sources positive for BBP, and infections in
HCP; (2) to investigate the impact of safety-engineered devices
on the incidence of percutaneous injuries; and (3) to analyze
percutaneous injuries associated with safety-engineered and
conventional devices by selected variables.
methods
This investigation was conducted at UNC Hospitals, an
853-bed tertiary care academic facility. Data on BBFE in HCP
were extracted from Occupational Health Service records
during the 15-year period (2000–2014) and were analyzed
retrospectively. Data on sources positive for pathogens (HBV,
HCV, HIV) and infections in HCP during 2000–2014 were
also analyzed. Variables (occupational group, location, device
type, nature of injury, activity, and personal protective
equipment) that were entered into the electronic database
during 2004–2014 were used for this study. All physicians in
our Occupational Health Service database were residents or
fellows. Attending physicians were excluded from this study
since they were captured in another database. Safety-
engineered devices included safety syringes (1mL and
≥3mL), introducers (central line, intravenous, and arterial),
butterfly-winged steel protected needles, Mylar-coated capil-
lary tubes, blunted sutures, insulin safety syringes, scalpel
safety blades, vacutainer push button collection sets, safety
needles, safety-holder blood culture devices, and retractable
lancets. The mean number of full-time equivalents at UNC
Hospitals per year was obtained from the UNC Hospitals
Department of Human Resources. Annual rates of BBFE or
percutaneous injuries were calculated as exposures or injuries
per 100 full-time equivalent employees.
Statistical analysis was performed using SAS, version 9.3
(SAS Institute). We applied generalized linear models to
measure the annual incidence rate difference (IRD) by
exposure type over time. Statistical significance and confidence
intervals were calculated by comparing these regression lines
to a line with a zero slope. A value of P< .05 was considered
statistically significant. This study was approved by the UNC
Institutional Review Board.
results
A total of 4,300 BBFE were reported during the 15-year period
(2000–2014) and included 3,318 percutaneous injuries
(77.2%), 894 exposures to mucous membrane/non-intact skin
(20.8%), and 88 injuries due to bite/scratch (2.0%).
The incidence rates for overall BBFE and percutaneous injuries
were significantly reduced (IRD, 1.72, P= .0003; and IRD,
1.65, P= .0002, respectively) (Figure 1), but exposures to
mucous membrane/non-intact skin and to bite/scratch
remained unchanged. Furthermore, the incidence rate for
percutaneous injuries was dramatically reduced during
2001–2006 (IRD, 1.37, P= .0079), compared with the rate
reduction observed during 2006–2014 (IRD, 0.32, P= .2383).
The annual frequency of percutaneous injuries accounted for
most blood and body fluid exposures during the study period
(relative mean [SD] percentage of BBFE: percutaneous
injuries, 77.5% [3.6%]; mucous membrane/non-intact skin,
20.5% [3.3%]; bite/scratch, 2.0% [1.6%]).
During 2004–2014, the 2,545 percutaneous injuries inclu-
ded 683 cases associated with safety-engineered devices
(26.8%) and 1,578 cases with conventional devices (62.0%).
There were 722 exposures to mucous membrane/non-intact
skin, which included 61 cases associated with safety-
engineered devices (8.4%) and 81 cases with conventional
devices (11.2%), but 580 cases (80.3%) were exposures of
unknown mechanism. The incidence rate for percutaneous
injuries associated with conventional devices was significantly
figure 1. Incidences of blood and body fluid exposures (BBFE)
by nature of injury among healthcare personnel, University of
North Carolina Hospitals, 2000–2014. Arrow shows the year 2001
of the Needlestick Safety and Prevention Act. FTE, full-time
equivalents.
reduced (IRD, 0.65, P= .003) (Figure 2). Percutaneous injuries
associated with safety-engineered devices increased (IRD, 0.22,
P= .1065) over the study period, though the trend was not
statistically significant. From 2004 to 2014, the relative
proportion of percutaneous injuries associated with conven-
tional devices decreased by 14%, but that of percutaneous
injuries associated with safety-engineered devices increased by
12% (relative mean [SD] percentage of percutaneous injuries:
conventional devices, 62.5% [4.8%]; safety-engineered devi-
ces, 26.4% [4.8%]; unknown, 11.1% [2.0%]). In 2014, of 272
percutaneous injuries reported at UNC Hospitals, 80 (29.4%)
were associated with safety-engineered devices.
BBFE associated with safety-engineered devices included
cases with safety syringes (n= 227), introducers (n= 222),
butterfly-winged steel protected needles (n= 122), insulin
safety syringes (n= 66), blunted sutures (n= 47), scalpel safety
blades (n= 38), vacutainer push button collection sets (n= 9),
safety needles (n= 6), safety-holder blood culture devices
(n= 4), Mylar-coated capillary tubes (n= 2), and retractable
lancets (n= 2). All types of safety-engineered devices that led
to BBFE in this study were user-activated devices. Character-
istics of BBFE associated with safety-engineered devices and
conventional devices are summarized in Tables 1 and 2. BBFE
associated with safety-engineered devices were more likely to
occur in nurses and inpatient wards, whereas BBFE associated
with conventional devices were in physicians and operating
rooms. The frequency of percutaneous injuries associated with
safety-engineered devices was 91.7%, whereas that of splash to
mucous membrane/non-intact skin was 8.2%. The most
frequent activities as a cause of BBFE associated with safety-
engineered devices (selected devices per overall devices for
each activity) were injecting through skin (safety syringe,
67.6%; insulin safety syringe, 17.9%), followed by starting an
intravenous line (introducer, 94.2%) and blood drawing
(butterfly-winged steel protected needle, 74.1%), whereas
suturing (non-blunted suture, 99.4%) was the most common
percutaneous injury associated with conventional devices.
Recapping (safety syringe, 60.4%; insulin safety syringe,
24.8%) was observed at a higher proportion of 13.6% in safety-
engineered device-associated percutaneous injuries. A total of
5.5% of HCP who had BBFE associated with safety-engineered
devices did not use gloves, whereas 92.6% of HCP used gloves
when exposures occurred.
Of the 4,300 BBFE during the 15-year period, there were 603
sources positive for BBP (14.0%), including 29 (0.7%) for
HBV, 397 (9.2%) for HCV, and 177 (4.1%) for HIV, whereas
there were 3,697 sources negative for a BBP (86.0%). The
incidence rate for overall BBP was significantly reduced (IRD,
0.45, P= .0011) (Figure 3). Of BBP, the incidence for HCV and
HIV was also significantly reduced (IRD, 0.31, P= .0017; and
IRD, 0.13, P= .034, respectively). However, the incidence for
HBV was not significantly reduced (IRD, 0.021, P= .1828),
although the incidence was low at less than 0.1 exposure per
100 full-time equivalents. The relative proportion of each BBP
fluctuated annually over the study period (relative mean [SD]
percentage of BBP: HBV, 5.0% [3.4%]; HCV, 66.0% [6.3%];
HIV, 29.1% [5.9%]). One healthcare provider contracted
HCV infection (0.25% in HCV exposures), although no
infections with HBV or HIV occurred.
discussion
Data from the Exposure Prevention Information Network
suggested that the estimated 385,000 percutaneous injuries
among HCP in the United States during 1997–1998 can be
reduced, as sharps-related injuries in nonsurgical hospital
settings decreased 31.6% during 2001–2006.13 Our work
extends previous work by evaluating the period from 2000 to
2014. We demonstrated significant overall reduction in BBFE
and percutaneous injuries that may be in part due to the
impact of safety-engineered devices and supported previous
studies showing successful reduction of overall percutaneous
injuries.11,14,15 Notably, safety-engineered devices worked well
to decrease the incidence of percutaneous injuries from the
figure 2. Incidences of percutaneous injuries associated with
safety-engineered devices among healthcare personnel, University of
North Carolina Hospitals, 2004–2014. FTE, full-time equivalents.






























Nurse 434 523 159 159 6 12 73 9 66 47 5 51
Medical doctor 196 888 54 154 26 90 1 3 0 1 36 500
Laboratory technician 45 53 0 3 2 2 38 2 0 0 0 0
Surgical technician 19 117 5 15 4 15 1 0 0 0 4 61
Environmental services 6 15 1 7 0 0 1 0 0 0 0 1
Nurse anesthetist 6 7 1 4 0 0 1 0 0 0 0 0
Other 39 113 7 25 0 6 7 2 0 3 2 16
Total 745 1716 227 367 38 125 122 16 66 51 47 629
Location
Inpatient ward 226 201 94 54 2 1 32 1 44 15 1 10
Intensive care unit 126 176 42 56 3 14 15 1 17 2 3 27
Operating room 93 645 28 65 14 49 3 1 0 1 23 410
Outpatient 58 100 30 40 2 0 6 1 2 0 2 30
Emergency room 56 67 9 24 1 2 19 0 0 2 0 20
Radiology/procedures 33 39 7 23 2 5 2 0 0 0 2 4
Laboratory 17 48 0 4 10 13 6 0 0 0 0 2
Post-anesthesia care
unit
9 11 2 6 0 0 2 1 0 0 1 2
Labor & delivery 8 57 3 9 0 4 3 1 0 0 1 33
Other 119 372 12 86 4 37 34 10 3 31 14 91
Total 745 1716 227 367 38 125 122 16 66 51 47 629

































683 1578 215 338 37 124 118 14 65 51 47 627
Splash to mucous membrane/
non-intact skin
61 81 12 28 1 1 4 1 0 0 0 1
Other 1 57 0 1 0 0 0 1 1 0 0 1
Total 745 1716 227 367 38 125 122 16 66 51 47 629
Activity
Injecting through skin 145 241 98 153 0 2 1 0 26 28 0 2
Starting intravenous injection 139 17 0 7 0 2 8 1 0 0 0 1
Blood drawing 112 131 12 32 0 0 83 11 0 0 0 0
Recapping 101 72 61 33 1 0 5 1 25 9 0 0
Disposal at sharps container 62 100 17 47 0 0 16 1 13 12 0 6
Suturing 38 481 0 0 0 0 0 0 0 35 478
Inappropriate location 35 62 20 13 2 11 2 0 1 1 1 19
Cleaning up/sorting 35 113 6 27 4 11 3 0 0 0 6 30
Passing instrument 20 104 8 11 6 9 2 1 0 0 3 62
Cutting/slicing 22 108 0 0 22 74 0 0 0 0 0 3
Patient care procedure 17 103 2 17 0 6 0 1 0 1 0 1
Surgical device manipulation 4 45 0 2 1 5 0 0 0 0 1 11
Collecting waste (pulling trash,
transporting trash)
2 13 1 3 0 0 0 0 0 0 0 1
Shaving 2 4 0 0 1 1 0 0 0 0 0 0
Holding retractor 1 14 0 2 1 0 0 0 0 0 0 6
Laboratory procedure 2 18 0 3 0 1 1 0 0 0 0 0
Sawing 1 8 0 0 0 0 0 0 0 0 1 4
Cauterizing 0 7 0 0 0 0 0 0 0 0 0 0
Dental procedure 0 7 0 1 0 0 0 0 0 0 0
Drilling 0 10 0 0 0 0 0 0 0 0 0 0
Emptying body fluid 0 8 0 2 0 0 0 0 0 0 0 0
Inserting drain 0 3 0 0 0 1 0 0 0 0 0 0
Suctioning 0 1 0 0 0 0 0 0 0 0 0 1
Wound care 1 9 0 3 0 0 0 0 0 0 0 0
Other 6 37 2 11 0 2 1 0 1 0 0 4
Total 745 1716 227 367 38 125 122 16 66 51 47 629
2001 Act to 2006, but this positive impact of safety-engineered
devices stabilized after 2006. Therefore, we need new inter-
ventions aimed at further reducing the injuries among HCP in
addition to using safety-engineered devices. Through a
multidisciplinary Needlestick Prevention Working Group,
UNC Hospitals is working toward eliminating needlestick
injuries via yearly education, placement of needle disposal
devices in every room, improved practices (no passing sharp
instruments directly person-to-person in the operating room),
double-gloving for high-risk surgical procedures that might
lead to damage to gloves (eg, orthopedic surgery), use of nee-
dleless connectors for intravenous lines, and availability of
blunted suture needles in the operating room. Unfortunately,
our data demonstrated that many injuries in the operating
room still result from suture needles. Although blunted suture
needles are available, they cannot be used in all cases (eg, skin
sutures) andmany surgeons choose not to use them even when
indicated. A previous article described substantial decreases in
percutaneous injuries after implementation of safety-
engineered devices, ranging 22%-100%.14 According to a
recent meta-analysis, training, safety-engineered devices, and
training combined with safety-engineered devices reduced the
rate of needlestick injuries by 34%, 49%, and 62%,
respectively.15 Our study identified that a considerable pro-
portion of percutaneous injuries are now associated with
safety-engineered devices. Further, the frequency of percuta-
neous injuries associated with safety-engineered devices is now
similar to the level of overall exposures to mucous membrane/
non-intact skin, suggesting the necessity for improving mea-
sures to prevent exposures from the use of HCP-activated
safety-engineered devices as well as conventional devices.
A retrospective review of percutaneous injuries from hollow
bore safety-engineered devices in the United States described
that approximately 75% of exposures occurred when the safety
function was not appropriately activated.12 In a French
multicenter study, the use of passive safety-engineered devices
was related to the lowest needlestick injuries rate.11 Percuta-
neous injuries associated with safety-engineered devices may
be caused by poor knowledge and instruction, improper use of
devices by HCP, mechanical failure of safety function, and
incomplete activation of the safety-engineered devices,11,12,16
suggesting that proper training is required since engineering
controls alone would not solve this issue.
In our study, there was also a concern for safety-engineered
device-associated exposures to mucous membrane/non-intact
skin as well as that most device types resulting in exposures to
mucous membrane/non-intact skin were unknown. Experi-
mental studies have described that macroscopic andmicroscopic
blood splatter from retractable intravenous devices or spatter
contamination due to manually activated safety-engineered
devices after syringe discharge and safety activation can occur,
although the risk for acquiring BBP from surface contamination
with blood and body fluids in healthcare settings is not well
known.17–19 More than 90% of HCP in our study used gloves
when exposures occurred, but the minority of BBFE was also
observed owing to failure to wear gloves and nonadherence to
personal protective equipment. Proper use of personal protective
equipment should be maintained since splashing may not be
detected. Safe work practices (eg, keeping contaminated hands
away from face; positioning patients) as well as rigorous com-
pliance with standard precautions are necessary to protect
mucous membranes/non-intact skin from BBFE.20
Our data showed that 3 major activities of safety-engineered
device-associated percutaneous injuries were injecting through
skin, placing intravenous catheters, and blood drawing,
accounting for half of all cases in this study. Recapping was also
found even when using safety-engineered devices. When safety-
engineered devices are newly adopted or percutaneous injuries
associated with specific type of safety-engineered devices are
found in healthcare facilities, enhanced education and training
program should focus on appropriate use of safety-engineered
devices as well as implementation of rigorous standard precau-
tions and other prevention measures against percutaneous
injuries (eg, double-gloving). Because BBFE remain a major
problem in operating rooms, continual education and training
of surgeons, introduction of passive safety-engineered devices
whenever possible, and further development of safety-
engineered devices in surgical fields are needed. Unfortunately,
figure 3. Incidences of blood and body fluid exposures by
source positive for bloodborne pathogens (BBP) among healthcare
personnel, University of North Carolina Hospitals, 2000–2014.
Arrow shows the year 2001 of the Needlestick Safety and Prevention
Act. FTE, full-time equivalents. HBV, hepatitis B virus; HCV,
hepatitis C virus; HIV, human immunodeficiency virus.
safety-engineered devices cannot be used in all circumstances
(eg, skin incisions); therefore, strict adherence to proper
management of sharp instruments must continue to be taught.
The incidence rate for BBFE to overall BBP was also reduced
in our study period. Importantly, the significant reduction in
BBFE to HCV among HCP should be noted since pre- or
postexposure prophylaxis against HCV infections is currently
unavailable. Our data demonstrated that a reduction in the
incidence of exposure of our employees to a BBP via a sharps
injury was due to the decrease in the incidence of such injuries,
not to a change in the frequency of BBP among source
patients. The risk of exposures to BBP can be reduced by
thorough adherence to the administrative, engineering, and
work practice controls.
There are several limitations for this study. First, our results
at single tertiary care academic facility may not be generalizable
but have been obtained on the basis of longitudinal trends.
Second, we captured only physicians who were residents or
fellows, although this group had 1,084 BBFE associated with
safety-engineered devices and conventional devices during
2004–2014. However, at any given time there were many more
residents/fellows providing direct patient care than attending
physicians. These trainees might have had a higher rate of
injuries than more experienced physicians. Also, the absolute
number of injuries among physicians is lower than the actual
number since attending physicians were not included in the
database. Third, the number of BBFE as a numerator may be
affected by underreporting, but our reporting system has been
maintained in a consistent manner during the study period. We
evaluated the annual incidence rates of BBFE by using full-time
equivalents as denominators, similar to the methods used by
other authors,6,15 but non-nursing occupation groups may have
a higher rate of exposures.1 Even if the limitations stated above
are considered, our data demonstrated that significant reduc-
tions in BBFE among HCP after introduction of safety-
engineered devices occurred over the past 15 years. Additional
efforts are needed to further reduce percutaneous injuries and
improve the design of safety-engineered devices.
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